Cogent Biosciences Files 8-K Report
Ticker: COGT · Form: 8-K · Filed: Jun 27, 2024 · CIK: 1622229
| Field | Detail |
|---|---|
| Company | Cogent Biosciences, INC. (COGT) |
| Form Type | 8-K |
| Filed Date | Jun 27, 2024 |
| Risk Level | low |
| Pages | 2 |
| Reading Time | 2 min |
| Key Dollar Amounts | $0.001 |
| Sentiment | neutral |
Sentiment: neutral
Topics: filing, corporate-actions
TL;DR
Cogent Biosciences filed an 8-K, mostly procedural stuff, but they used to be Unum Therapeutics.
AI Summary
On June 27, 2024, Cogent Biosciences, Inc. filed an 8-K report. The filing primarily concerns "Other Events" and "Financial Statements and Exhibits." It also notes a former company name, Unum Therapeutics Inc., which changed its name on April 2, 2018.
Why It Matters
This filing provides official updates and disclosures from Cogent Biosciences, Inc. to the SEC, which can impact investor understanding of the company's status.
Risk Assessment
Risk Level: low — The filing is a standard 8-K report and does not appear to contain any new material events or significant financial disclosures that would immediately alter risk.
Key Players & Entities
- Cogent Biosciences, Inc. (company) — Registrant
- Unum Therapeutics Inc. (company) — Former company name
- 001-38443 (company) — SEC File Number
- 46-5308248 (company) — I.R.S. Employer Identification No.
- 275 Wyman Street, 3rd Floor Waltham, Massachusetts 02451 (company) — Principal executive offices address
- June 27, 2024 (date) — Date of Report
FAQ
What is the primary purpose of this 8-K filing for Cogent Biosciences, Inc.?
The primary purpose of this 8-K filing is to report "Other Events" and "Financial Statements and Exhibits" as of June 27, 2024.
What was Cogent Biosciences, Inc. formerly known as?
Cogent Biosciences, Inc. was formerly known as Unum Therapeutics Inc., with a name change date of April 2, 2018.
What is the SEC file number for Cogent Biosciences, Inc.?
The SEC file number for Cogent Biosciences, Inc. is 001-38443.
Where are Cogent Biosciences, Inc.'s principal executive offices located?
Cogent Biosciences, Inc.'s principal executive offices are located at 275 Wyman Street, 3rd Floor, Waltham, Massachusetts 02451.
What is the I.R.S. Employer Identification Number for Cogent Biosciences, Inc.?
The I.R.S. Employer Identification Number for Cogent Biosciences, Inc. is 46-5308248.
Filing Stats: 467 words · 2 min read · ~2 pages · Grade level 10.5 · Accepted 2024-06-27 08:05:31
Key Financial Figures
- $0.001 — nge on which registered Common stock, $0.001 Par Value COGT The Nasdaq Global Se
Filing Documents
- d792910d8k.htm (8-K) — 24KB
- d792910dex991.htm (EX-99.1) — 9KB
- g792910g0626051622951.jpg (GRAPHIC) — 3KB
- 0001193125-24-169756.txt ( ) — 160KB
- cogt-20240627.xsd (EX-101.SCH) — 3KB
- cogt-20240627_lab.xml (EX-101.LAB) — 18KB
- cogt-20240627_pre.xml (EX-101.PRE) — 11KB
- d792910d8k_htm.xml (XML) — 4KB
Financial Statements and Exhibits
Financial Statements and Exhibits. (d) Exhibits Exhibit No. Description 99.1 Press release dated June 27, 2024. 104 The cover page from the Company's Current Report on Form 8-K formatted in Inline XBRL.
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Date: June 27, 2024 COGENT BIOSCIENCES, INC. By: /s/ Evan Kearns Evan Kearns Chief Legal Officer and Corporate Secretary